Evidence map›Paper›PMID 28057892›Full record

ReviewClinical science (London, England : 1979)2017

Hypothalamic and inflammatory basis of hypertension.

Sinan Khor, Dongsheng Cai

Open access · greenAbstract readReview
In one paragraph

Review in Clinical science (London, England : 1979), 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
1.8field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 39 citations in OpenAlex.

  1. Trial
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Hypothalamic inflammation in metabolic disorders and aging.Cellular and molecular life sciences : CMLS · 2021
    Review
  14. Review
  15. Review
  16. Article
  17. Review
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Sinan KhorDepartment of Molecular Pharmacology, Albert Einstein College of Medicine, Bronx, NY 10461, U.S.A.
Dongsheng CaiDepartment of Molecular Pharmacology, Albert Einstein College of Medicine, Bronx, NY 10461, U.S.A. dongsheng.cai@einstein.yu.edu.
Albert Einstein College of Medicine · US

Funding

The Hypothalamic Basis of AgingR01AG031774 · NIA · ALBERT EINSTEIN COLLEGE OF MEDICINE, INC · PI Dongsheng Cai · 2010 to 2026
$6.3M
Role of IKK-Beta/NF-KappaB in Hypothalamic Dysregulation of Energy BalanceR01DK078750 · NIDDK · UNIVERSITY OF WISCONSIN-MADISON · PI CAI, DONGSHENG · 2008 to 2017
$3.8M
Hypothalamic HIF in Nutrient Sensing and Metabolic ControlR01DK099136 · NIDDK · ALBERT EINSTEIN COLLEGE OF MEDICINE, INC · PI CAI, DONGSHENG · 2014 to 2018
$2.1M
Hypothalamic IKK-beta in obesity-related hypertensionR01HL113180 · NHLBI · ALBERT EINSTEIN COLLEGE OF MEDICINE, INC · PI CAI, DONGSHENG · 2013 to 2016
$1.9M
NHLBI NIH HHS R01 HL113180NIA NIH HHS R01 AG031774NIDDK NIH HHS R01 DK078750NIDDK NIH HHS R01 DK099136
6 · The paper itself

Abstract

Hypertension is a major health problem with great consequences for public health. Despite its role as the primary cause of significant morbidity and mortality associated with cardiovascular disease, the pathogenesis of essential hypertension remains largely unknown. The central nervous system (CNS) in general, and the hypothalamus in particular, are intricately involved in the development and maintenance of hypertension. Over the last several decades, the understanding of the brain's role in the development of hypertension has dramatically increased. This brief review is to summarize the neural mechanisms of hypertension with a focus on neuroendocrine and neurotransmitter involvement, highlighting recent findings that suggest that hypothalamic inflammation disrupts key signalling pathways to affect the central control of blood pressure, and therefore suggesting future development of interventional strategies that exploit recent findings pertaining to the hypothalamic control of blood pressure as well as the inflammatory-sympathetic mechanisms involved in hypertension.

Indexed as

Blood PressureAnimalsHumansHypertensionHypothalamic DiseasesHypothalamusInflammationMolecular Targeted Therapycentral nervous systemhypertensionHypertension and inflammationhypothalamusinflammationSignalling

Identifiers

PMID28057892
PMCPMC5509160
OpenAlexW2568611837

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.